Transcripts Xilio Therapeutics, Inc.

Actions

Marché Fermé - Nasdaq 22:00:00 09/10/2026			Varia. 5j.	Varia. 1 janv.
9,050 ^USD	+0,44 %		+1,57 %	+0,97 %

28/09	Xilio Therapeutics, Inc. annonce la nomination de Yariv J. Houvras, M.D., Ph.D., au poste de directeur médical	CI
12/08	Xilio Therapeutics, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

11/11	Transcript : Xilio Therapeutics, Inc. - Special Call
12/02/25	Transcript : Xilio Therapeutics, Inc. - Special Call
22/01/25	Transcript : Xilio Therapeutics, Inc. - Special Call
07/11/24	Transcript : Xilio Therapeutics, Inc. - Special Call
04/09/24	Transcript : Xilio Therapeutics, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-04-2024 07:00 AM
28/03/24	Transcript : Xilio Therapeutics, Inc. - Special Call
06/11/23	Transcript : Xilio Therapeutics, Inc. - Special Call
11/09/23	Transcript : Xilio Therapeutics, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-11-2023 02:55 PM
17/08/23	Transcript : Xilio Therapeutics, Inc. - Special Call
23/02/23	Transcript : Xilio Therapeutics, Inc. Presents at Citi's 2023 Virtual Oncology Leadership Summit, Feb-23-2023 09:00 AM
01/12/22	Transcript : Xilio Therapeutics, Inc. - Special Call
13/09/22	Transcript : Xilio Therapeutics, Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-13-2022 02:55 PM